Population Aging

Alzheimer's Today

The continuing symposium for research, care, policy and education.

CME Activities


An Update on Scientific Advances and Clinical Strategies in Alzheimer’s Disease: Report From CTAD 2016

The 9th annual meeting of Clinical Trials on Alzheimer’s Disease (CTAD) was held in San Diego, California, December 8-10, 2016. CTAD has become one of the most important scientific meetings in the Alzheimer’s disease (AD) area. It brings together today’s global leaders in AD to discuss new results, candidate therapeutics, and methodological issues important to the development of the next generation of AD treatments. In this activity, two experts summarize the key learnings from this year’s conference.

Upon completion of this activity, participants will be better able to:

  1. Discuss recent advances in clinical trials of AD
  2. Identify therapies in development for the treatment of AD
  3. Analyze the use of biomarkers to identify patients with early-stage AD
Click Here To Access Activity

In Focus: The Amyloid-Tau Relationship in the Pathophysiology of Alzheimer’s Disease

The content for this activity is based on the satellite symposium, “In Focus: The Amyloid-Tau Relationship in the Pathophysiology of Alzheimer’s Disease” that was presented at The Alzheimer's Association International Conference® 2016 (AAIC®) on July 26, 2016. The pathophysiology of Alzheimer’s disease (AD) involves both amyloid and tau proteins; the exploration of the respective roles of these proteins in neuronal loss and neurodegeneration has important implications for future therapeutic interventions. PET imaging of amyloid and tau plays a critical role in understanding neurodegeneration patterns and clinical manifestations of AD.

Upon completion of this activity, participants will be better able to:

  1. Define recent insights into the role of amyloid and tau proteins in the pathophysiology of AD
  2. Analyze the advances in imaging of amyloid and tau
Click Here To Access Activity

An Update on Scientific Advances and Clinical Strategies in Alzheimer’s Disease: Report from AAIC 2016

The Alzheimer's Association International Conference® 2016 (AAIC®) annual meeting was held in Toronto, Canada, July 22-28, 2016. AAIC is the world's largest forum for the dementia research community. Researchers, clinicians, care providers, and students from more than 70 countries gather at AAIC to network and discuss the latest dementia study results, theories, and discoveries. In this activity, 2 experts summarize the key learnings from this year’s conference.

Upon completion of this activity, participants will be better able to:

  1. Discuss recent advances in clinical trials of AD
  2. Identify symptomatic therapies in development for the treatment of AD
  3. Analyze the use of biomarkers to identify patients with early-stage AD
Click Here To Access Activity